Laube B, Winkler S, Ladstetter B, Scheller T, Schwarz L R
GSF-National Research Centre for Environment and Health, Institute of Toxicology, Neuherberg/Munich, Germany.
Arch Toxicol. 2000 Sep;74(7):379-87. doi: 10.1007/s002040000137.
We developed a new two-chamber system for the coculture of hepatocytes and fecal microflora under aerobic and anaerobic conditions, respectively, to investigate the sequential metabolism of chemicals by the liver and microflora in vitro. The culture device consisted of two chambers separated by a permeable polycarbonate membrane. In the aerobic compartment, hepatocytes were cultivated as a monolayer on the membrane and in the anaerobic compartment fecal microflora as a suspension. To characterize the metabolic capacity of the microflora and hepatocytes, various marker enzymes were studied. Azoreductase, nitroductase, beta-glucuronidase, beta-glucosidase and sulphatase were tested in the microflora of the feces from three volunteers who had had significantly different eating habits for years (daily meat, mixed diet, vegetarian). The microflora exhibited significant activities and the various enzymes differed only moderately in the samples from the three volunteers. For rat hepatocytes the activities of various cytochrome P450 forms and conjugating enzymes served as markers. The enzyme activities were tested in the coculture system during a 4-h culture period intended for the test protocol. Deethylation of ethoxycoumarin and 2alpha-, 6beta- and 16alpha-hydroxylation of testosterone decreased by about 30%, 25%, 40% and 20%, respectively, while there was no loss of glucuronidation and sulphonation of 3-OH-benzo(a)pyrene nor of glutathione conjugation of 1-chloro-2,4-dinitrobenzene during the 4-h culture period. The activities of the tested hepatic phase I and II enzymes were not changed after coculture of the hepatocytes with the microflora for 4 h. The applicability of the in vitro system for studying the metabolic interaction of liver and microflora was demonstrated using 7-ethoxycoumarin and the developmental drug EMD 57033, a thiadiazinon derivative from Merck KGaA, as model compounds. Both compounds were oxidized and conjugated by liver cells. In the coculture of hepatocytes and fecal microflora the resulting glucuronides and sulphoconjugates were split by hydrolytic enzymes of the intestinal microflora.
我们开发了一种新的双室系统,用于分别在需氧和厌氧条件下进行肝细胞与粪便微生物群的共培养,以研究肝脏和微生物群在体外对化学物质的顺序代谢。培养装置由两个由可渗透聚碳酸酯膜隔开的室组成。在需氧室中,肝细胞以单层形式培养在膜上,在厌氧室中,粪便微生物群以悬浮液形式培养。为了表征微生物群和肝细胞的代谢能力,研究了各种标记酶。对三名多年来饮食习惯差异显著(每日肉食、混合饮食、素食)的志愿者粪便中的微生物群测试了偶氮还原酶、硝基还原酶、β-葡萄糖醛酸酶、β-葡萄糖苷酶和硫酸酯酶。微生物群表现出显著活性,三种志愿者样本中的各种酶仅存在适度差异。对于大鼠肝细胞,各种细胞色素P450形式和结合酶的活性用作标记。在用于测试方案的4小时培养期内,在共培养系统中测试了酶活性。乙氧香豆素的脱乙基作用以及睾酮的2α-、6β-和16α-羟基化作用分别降低了约30%、25%、40%和20%,而在4小时培养期内,3-羟基苯并(a)芘的葡萄糖醛酸化和磺化作用以及1-氯-2,4-二硝基苯的谷胱甘肽结合作用均未丧失。肝细胞与微生物群共培养4小时后,所测试的肝脏I期和II期酶的活性没有变化。使用7-乙氧香豆素和开发药物EMD 57033(默克集团的一种噻二嗪酮衍生物)作为模型化合物,证明了该体外系统在研究肝脏与微生物群代谢相互作用方面的适用性。两种化合物均被肝细胞氧化并结合。在肝细胞与粪便微生物群的共培养中,产生的葡萄糖醛酸苷和硫酸共轭物被肠道微生物群的水解酶分解。